Figure 1From: A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells Suppression of neuroblastoma cell growth by LY379196. Neuroblastoma IMR-32 (A), SH-SY5Y (B), and SK-N-BE(2) (C) cells were grown for four (A and B) or three (C) days in regular growth medium supplemented with increasing concentrations of LY379196. Thereafter the number of viable cells was determined with an MTT assay. Data are expressed as percent of values obtained in the absence of LY379196 and are mean ± SEM (n = 9–18 from 3–6 separate experiments).Back to article page